NCT06951893 Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectories in Obese Patients Following Bariatric Surgery
| NCT ID | NCT06951893 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Metropole Savoie |
| Condition | Obesity, Morbid |
| Study Type | INTERVENTIONAL |
| Enrollment | 165 participants |
| Start Date | 2025-06-17 |
| Primary Completion | 2030-09-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 165 participants in total. It began in 2025-06-17 with a primary completion date of 2030-09-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to identify pre-operative phenotypic determinants predictive of quality of life trajectories in post-bariatric surgery patients. In addition, this study will have as a secondary objective the highlighting of a potential link between post-surgery quality of life trajectories and those of anxiety/depression scores, eating behaviors and body mass indices. This study will be conducted during the usual care of patients undergoing the GEROM73 program, lasting a total of 30 months. The GEROM73 program includes care for the six months preceding bariatric surgery and the 24 months following surgery. This program supports patients throughout their bariatric care.. Throughout the GEROM73 program, patients will complete questionnaires on anxiety, depression, eating disorders, Impact of Weight on Quality Of Life. Patients' weight, body mass index and body schema will also be measured throughout the GEROM program.
Eligibility Criteria
Inclusion Criteria: * patient \> 18years old * Integrated into the GEROM73 surgical program and starting the intra-hospital program Exclusion Criteria: * Patients in a state of psychiatric decompensation * Patients with cognitive disorders * Patients with difficulties understanding the French language, spoken or written * Pregnant, parturient, or breastfeeding women
Contact & Investigator
Cécile BOSSU ESTOUR
PRINCIPAL INVESTIGATOR
CH Metropole Savoie
Frequently Asked Questions
Who can join the NCT06951893 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obesity, Morbid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06951893 currently recruiting?
Yes, NCT06951893 is actively recruiting participants. Contact the research team at urc@ch-metropole-savoie.fr for enrollment information.
Where is the NCT06951893 trial being conducted?
This trial is being conducted at Chambéry, France.
Who is sponsoring the NCT06951893 clinical trial?
NCT06951893 is sponsored by Centre Hospitalier Metropole Savoie. The principal investigator is Cécile BOSSU ESTOUR at CH Metropole Savoie. The trial plans to enroll 165 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.